Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multidrug resistance protein 1 (MDR1/P-glycoprotein/ABCB1) is an essential efflux pump responsible for protecting tissues from toxins but also mediates clinically significant drug resistance—especially during cancer treatment—by reducing intracellular accumulation through active export powered by ATP hydrolysis.
ATP-dependent efflux of a broad range of substrates from the cell, decreasing intracellular drug concentrations.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multidrug Resistance Protein 1 (MDR1).